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Abstract: Toxin/antitoxin (TA) systems are nearly universal in prokaryotes; toxins are 
paired with antitoxins which inactivate them until the toxins are utilized. Here we explore 
whether toxins may function alone; i.e., whether a toxin which lacks a corresponding 
antitoxin (orphan toxin) is physiologically relevant. By focusing on a homologous protein 
of the membrane-damaging toxin GhoT of the Escherichia coli GhoT/GhoS type V TA 
system, we found that YdcX (renamed OrtT for orphan toxin related to tetrahydrofolate) is 
toxic but is not part of TA pair. OrtT is not inactivated by neighboring YdcY (which is 
demonstrated to be a protein), nor is it inactivated by antitoxin GhoS. Also, OrtT is not 
inactivated by small RNA upstream or downstream of ortT. Moreover, screening a 
genomic library did not identify an antitoxin partner for OrtT. OrtT is a protein and its 
toxicity stems from membrane damage as evidenced by transmission electron microscopy 
and cell lysis. Furthermore, OrtT reduces cell growth and metabolism in the presence of both 
antimicrobials trimethoprim and sulfamethoxazole; these antimicrobials induce the stringent 
response by inhibiting tetrahydrofolate synthesis. Therefore, we demonstrate that OrtT acts 
as an independent toxin to reduce growth during stress related to amino acid and  
DNA synthesis. 
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1. Introduction 
Folic acid (vitamin B9) plays a pivotal role in both prokaryotic and eukaryotic cells for the 
biosynthesis of many cellular components [1]. Humans cannot synthesize folates and so depend on an 
exogenous supply, whereas most prokaryotes synthesize this essential cofactor de novo [2] which 
makes the folate metabolic pathway an interesting target in urinary tract infections [3], chemotherapy, 
and malarial disease treatment [4]. The reduced form of folic acid, tetrahydrofolate (THF) serves as the 
donor of one-carbon units in myriad metabolic pathways involved in the formation of purines, thymidine, 
glycine, and methionine [5]. THF is also required for synthesizing formylmethionyl-tRNAfMet which is 
essential for initiation of protein synthesis in bacteria [6]. Depletion of the intracellular THF pool causes 
“thymineless death” in rich medium where bacteria undergo cell-death due to thymine starvation or 
leads to a stringent response in minimal medium where the bacterial population enters a non-dividing 
state due to amino acid starvation [5]. The stringent response involves accumulation of the regulatory 
alarmone guanosine tetraphosphate (ppGpp) [7]. One of the ways to cope with nutritional stress for 
bacteria is activation of toxin-antitoxin (TA) systems through ppGpp to achieve a non-metabolizing 
dormancy state [8,9]. This quiescent state is called “persistence” in which bacterial cells are tolerant  
to antibiotics. 
TA systems are diverse and abundant in free-living prokaryotes [10]. A TA system usually consists 
of two genes in an operon that encode for a stable toxin that damages the bacterial cell that makes  
the toxin (rather than affecting another cell) by inhibiting a critical physiological step and a labile 
antitoxin, which protects the host by blocking the deleterious activity of the toxin [11]. The cellular 
targets of these toxins are quite diverse including DNA replication machinery, mRNA, protein 
synthesis, cell membranes, ATP synthesis [12], and DNA [13]. To date, five types of TA systems have 
been categorized depending on the role of the antitoxins. In type I systems, antitoxin RNA silences the 
toxin by binding to the toxin mRNA [14], and in type III systems, the antitoxin RNA binds to the toxin 
via its organized repeat motifs [15]. In type II, IV, and V systems, the protein antitoxin either directly 
binds the toxin (type II) [16], interferes with the binding of the toxin to its target (type IV) [17],  
or degrades the toxin mRNA via its specific enzymatic endoribonuclease activity (type V) [18].  
The recently characterized type V TA system comprises of a membrane lytic toxin, GhoT and an 
unique antitoxin, GhoS which is not labile during stress and does not participate in transcriptional 
control of the TA pair; rather, it functions as an antitoxin by specifically cleaving ghoT mRNA. 
Although initially discovered related to plasmid maintenance [19], their ubiquitousness in bacterial 
chromosomes have made TA loci the subject of intense scrutiny to unveil their enigmatic role in cell 
physiology. In most cases, deletion of a single TA pair rarely has any impact on cell physiology [20] 
and ectopic expression of toxins is often required to study their effect on bacterial growth. For example, 
persistence was unchanged with deletion of single toxin genes even with severe antibiotic stress [21] 
whereas successive deletion of 10 type II TA systems led to reduced persistence level [20]. 
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Despite these difficulties in determining physiological roles, TA systems are clearly phage 
inhibition systems [15,22,23] and stress-response elements [24,25]. There is also increasing evidence 
supporting the role of TA systems in achieving bacterial persistence [26–28]. For instance, deletion of 
type II toxin gene mqsR and the TA locus mqsRA both reduced persistence level [27]. Supporting this 
result, type I toxin TisB was directly linked with persistence as absence of tisAB/istR locus led to 
significant reduction in ciprofloxacin induced persistence [28]. Furthermore, expression of TA modules 
(RelBE, MazEF, DinJYafQ, MqsR, YoeB) were induced in a transcriptome study performed with 
isolated E. coli persister cells [29]. 
Although the classical paradigm for TA systems involves adjacent co-transcribed genes encoding a 
toxin and its specific antitoxin, several studies have described exceptions to this model such as cross 
interactions between non-cognate pairs [10,30,31]. Note that these cross interactions are distinct from 
TA cascades in which one TA system regulates another as shown with MqsR/MqsA regulation of 
GhoT/GhoS [32]. Another exception to the general TA concept is the extrinsic regulation of toxins by 
antitoxins encoded in trans. For example, the chromosomally encoded ccdEch antitoxin was shown  
to act on a plasmid-encoded toxin ccdF to protect the cells from postsegregational killing [33].  
Furthermore, MazF-mediated toxicity was inhibited by the remotely-encoded antitoxin MrpC in 
Myxococcus xanthus [34]. In addition to these exceptions, toxic endolysin genes are often found in cryptic 
prophage remnants such as PhyL in Bacillus anthracis [35] and LysA in Streptococcus gordonii [36] 
without the antitoxin genes. 
Along with the consistent high specificity of nearly all toxins for their adjacent antitoxins,  
all but one of the characterized TA systems consists of two-components with the exception of the 
three-component system ω-ε-ζ of Streptococcus pyogenes [37]. Here, we demonstrate the importance 
of a one-component system by characterizing a new toxin, YdcX (renamed OrtT for orphan toxin 
related to tetrahydrofolate) in the chromosome of the model organism E. coli K12. We demonstrate 
that this new toxin is similar to GhoT of the type V GhoST TA system, but it lacks an antitoxin and is 
not regulated by GhoS antitoxin; hence, it is an orphan toxin. We also determine that OrtT functions as 
a toxin by damaging the cell membrane and reducing intracellular ATP level and that OrtT has a 
distinct physiological role, which is to reduce cellular growth and metabolism in response to the 
stringent response induced by depletion of THF. 
2. Results 
2.1. OrtT is a Proteic Toxin that Increases Persistence 
OrtT is the same size (57 aa) and shares 63% protein identity with toxin GhoT (Figure 1A).  
Hence, we investigated whether OrtT is a toxin. We found that production of OrtT from pCA24N-ortT 
caused severe growth inhibition (Figure 1B,C); hence, OrtT is a toxin. To determine if OrtT works  
as a protein toxin, the start codon was mutated from ATG (Met) to ACG (Thr) to generate  
pCA24N-ortTACG. The wild-type strain harboring pCA24N-ortTACG with inactivated protein OrtT 
was able to grow with full induction (Figure 1B). These results demonstrate that OrtT is a toxin that 
functions as a protein. 
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Figure 1. OrtT is a proteic toxin that increases persistence. (A) Sequence homology 
between GhoT and OrtT is shown, and the conserved Phe38 residue is boxed; (B) Growth 
of BW25113 wild-type cells harboring different plasmids in LB medium with 
chloramphenicol (30 µg/mL) with 1 mM IPTG introduced at 1h. Two independent cultures 
were evaluated. Error bar represent standard deviation; (C) Growth of BW25113 wild-type 
cells harboring different plasmids on LB plates with chloramphenicol (30 µg/mL) with or 
without 1 mM IPTG. Two independent cultures were evaluated; (D) Persistence assay with 
BW25113 wild-type cells after 3 h ampicillin (100 µg/mL) or ciprofloxacin (5 µg/mL) 
treatment with or without OrtT production. Two independent cultures were evaluated.  
Error bar represent standard deviation. Plasmid abbreviations: Empty, pCA24N; OrtT,  
pCA24N-ortT; OrtTACG, pCA24N-ortTACG which lacks a start codon. 
Ectopic expression of toxins such as MqsR increases persistence [27] since cells have reduced 
metabolism [38]. Hence, we tested if OrtT production influences persister cell formation by producing 
OrtT from pCA24N-ortT. As expected, persistence increased 430 fold with ampicillin treatment and  
27 fold with ciprofloxacin treatment relative to cells with an empty vector (Figure 1D). Note that, 
generally persistence fold changes are lower by one to two orders of magnitude for ciprofloxacin 
treatment compared to ampicillin treatment [39] and that the induction conditions of ortT are different 
for the experiments in Figure 1B,D. Together, these results corroborate that OrtT is a bona-fide toxin 
that helps the cells to enter a dormant state. 
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2.2. OrtT Lyses Cells through Membrane Damage and Reduces ATP 
Like GhoT, OrtT is predicted to be a hydrophobic inner-membrane protein with two transmembrane 
domains (residue 6 to 26 and 34 to 54) [40]. To investigate the structural resemblance of OrtT with 
GhoT, we modelled both proteins using PHYRE2 [41]. The modelled monomeric proteins have  
high structural identity as can be seen from the superimposed protein structures in Figure 2A.  
Previously, introduction of the F38R substitution abolished GhoT toxicity [42]; hence, since the Phe38 
residue is conserved in both proteins (boxed nt, Figure 1A), we tested whether Phe38 bears the same  
functional-significance for OrtT toxin by constructing pCA24N-ortTF38R. As shown in Figure 2B, 
OrtT-mediated toxicity was reduced for OrtTF38R. These results suggest that OrtT is likely a 
membrane protein that functions in a manner similar to GhoT. Note that, we tried to visualize OrtTF38R 
via Western blot analysis but like GhoT [42], this toxic protein could not be detected (Figure S1). 
Production of GhoT leads to cell lysis [18]. Hence, to characterize toxin OrtT, we tested if ectopic 
expression of ortT lyses cells and found that production of OrtT in wild-type cells caused 99.99% of 
the bacterial population to undergo cellular lysis within two hours after induction (Figure 2C).  
This suggests OrtT damages the cell membrane. 
To confirm that OrtT causes membrane damage, we performed transmission electron microscopy 
(TEM) with wild-type cells producing toxin OrtT and compared them to wild-type cells with an empty 
vector. We found there was a dramatic change in cell morphology due to OrtT production; the two  
most common phenomena were (i) nucleoid condensation and enlargement of the periplasmic space;  
and (ii) cellular component leakage leading to almost a hollow cytoplasmic space (top two panels,  
Figure 2D). In contrast, cells with the empty vector looked healthy with an intact periplasm  
and cytoplasm. 
Next, we tested whether OrtT-mediated membrane damage leads to loss of cellular ATP level by 
measuring intracellular ATP concentration. Production of OrtT caused a 27-fold loss in ATP level  
when compared with the empty vector strain (Figure 2E). This suggests that proton-motive force  
(PMF) is disrupted in OrtT producing cells. Collectively, these results corroborate that OrtT is most 
likely a membrane protein that leads to cell lysis via membrane damage and depletion of intracellular 
ATP pool. 
2.3. OrtT is an Orphan Toxin 
To further characterize this new toxin, we explored if it forms a toxin-antitoxin pair by interacting 
with other protein/RNA. Although ortT-ydcY does not form an operon (Figure 3A), we tested whether 
YdcY can act as an antitoxin by constructing pCA24N-ortT-ydcY (Figure S2A). Using this plasmid we 
found that YdcY does not act as an antitoxin as OrtT-mediated toxicity was not reduced when YdcY 
was co-produced with OrtT (Figure 3B). Note that YdcY was confirmed to be a protein by running an 
SDS-PAGE (Figure S3). 
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Figure 2. OrtT causes cell lysis via membrane damage and reduces cellular ATP.  
(A) Superimposed protein model of GhoT (green) and OrtT (cyan). Phe38 is blue for GhoT 
and yellow for OrtT, and Ile21 is red for GhoT and magenta for OrtT; (B) Growth of 
BW25113 wild-type cells carrying different plasmids in LB medium with chloramphenicol 
(30 µg/mL) with 0.1 mM IPTG introduced at 1h. Two independent cultures were 
evaluated. Error bar represents standard deviation; (C) Cell lysis assay with BW25113 
wild-type cells producing OrtT or with empty vector. LB medium was used with 
chloramphenicol (30 µg/mL) and 2 mM IPTG (added at OD600 0.5). Two independent 
cultures were evaluated. Error bar represents standard deviation; (D) TEM images of 
BW25113 wild-type cells producing OrtT (top two rows) or with empty vector (bottom row). 
Left column shows longitudinal sections, and the right column shows horizontal sections. The 
blue arrow shows the enlargement of the periplasmic space, the red arrow shows nucleoid 
condensation, and the green arrow shows the empty cytoplasmic space. Scale bar indicates  
0.5 µm; (E) Change in relative intracellular ATP level due to OrtT production in BW25113 
wild-type cells. LB medium was used with chloramphenicol (30 µg/mL) and cells were treated 
with 1 mM IPTG (added at OD600 0.5) for 3 h. The ATP levels were calculated as RLU/OD600 
(relative light units/optical cell density at 600 nm) and normalized to that of the strain with the 
empty vector pCA24N. Plasmid abbreviations: Empty, pCA24N; OrtT, pCA24N-ortT; 
OrtTF38R, pCA24N-ortTF38R having Phe38 substituted by Arg; GhoT, pCA24N-ghoT; 
GhoTF38R, pCA24N-ghoTF38R having similar F38R substitution. 
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Figure 3. OrtT is an orphan toxin. (A) The chromosomal region around ortT gene in  
E. coli. ortT is represented by a red arrow and ydcY is shown by the grey arrow. Three 
predicted promoters (i.e., σE, σD, and σH) for ortT and one predicted promoter (i.e., σD) for 
ydcY are shown by dashed arrows; (B) Growth of BW25113 wild-type cells harboring 
empty plasmid, plasmid carrying ortT only or ortT with ydcY, ghoS, or the intervening 
region upstream and downstream of ortT (UTR) in LB medium with chloramphenicol  
(30 µg/mL) with 1 mM IPTG introduced at 1 h. Two independent cultures were evaluated.  
Error bar represents standard deviation; (C) Growth on LB plates with chloramphenicol  
(30 µg/mL) with or without 1 mM IPTG. Plasmid abbreviations: Empty, pCA24N; OrtT, 
pCA24N-ortT; OrtT-YdcY, pCA24N-ortT-ydcY; OrtT-GhoS, pCA24N-ortT-ghoS;  
OrtT-UTR, pCA24N-ortT-UTR. Two independent cultures were evaluated. 
GhoS is the antitoxin for GhoT, and it functions by cleaving the ghoT transcript [18].  
Since OrtT is similar to GhoT, we tested whether ortT mRNA is a substrate for GhoS by constructing  
pCA24N-ortT-ghoS (Figure S2B). We found that GhoS does not attenuate OrtT toxicity (Figure 3B). 
These plasmids (i.e., pCA24N-ortT-ydcY and pCA24N-ortT-ghoS) were constructed in a way that  
the toxin and putative antitoxin genes are under the control of the same promoter. Note that such  
co-expression of toxins and antitoxins from the same promoter has been used for different TA systems 
such as MqsRA (Figure S4) [43] and VapBC [44]. 
We also considered the possibility of OrtT to be regulated by an RNA antitoxin. Type I toxin genes 
are generally secluded by large intergenic distances ranging from 492 to 1181 bp upstream and  
282–708 bp downstream [14]. Hence, it was unlikely for OrtT to be a member of type I TA family 
considering the relatively small intergenic distances (i.e., 194 bp upstream and 85 bp downstream). 
Nonetheless, we tested for RNA interactions by cloning the upstream and downstream intergenic region 
between ortT and neighboring genes yncL and ydcY, respectively, to construct pCA24N-ortT-UTR 
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(Figure S2C,D). We found that RNA both upstream and downstream of ortT did not reduce its toxicity 
(Figure 3B). Note that previously such a construct has led us to identify the RNA antitoxin partner 
RalA for the toxin RalR [13]. 
To verify that an antitoxin for OrtT is not coded elsewhere within the genome, we performed an 
extensive search for potential antitoxins by constructing a genomic library by partially digesting 
BW25113 genomic DNA and cloning the DNA fragments downstream of ortT gene in the  
pCA24N-ortT-B construct. The library of cloned plasmids was then transformed into BW25113 cells 
and screened for an antitoxin by growing the transformants in presence of IPTG to induce ortT 
expression. With about 3-fold coverage of the genome and an average insert size of 622 bp, we found 
that the constructs that were able to survive OrtT toxin expression were those with defective plasmids 
(i.e., those lacking a functional ortT gene). Therefore, no antitoxin partner for OrtT was identified from 
these four sets of experiments which confirm that OrtT is an orphan toxin. 
2.4. Physiological Relevance of Toxin OrtT 
Because both OrtT and GhoT are toxins that corrupt the membrane, we investigated if these two 
toxins serve a similar role in cell physiology. GhoT decreases cellular metabolism in the presence of 
carbenicillin and cefoxitin helping cells withstand this kind of membrane stress [42]. Hence, we first 
investigated whether OrtT was involved in the same pathway to slow metabolism in presence of 
carbenicillin. Surprisingly, OrtT was not involved in the stress response against carbenicillin  
(Figure 4A) since cells which lack OrtT (i.e., ∆ortT ∆Kan) had low metabolism like wild-type cells 
whereas cells lacking GhoT (i.e., ∆ghoT ∆Kan) showed high metabolism under this stressful condition. 
Note that only strains which lack the antibiotic resistance marker were used so that the only difference 
between the strains is deletion of the toxin gene. 
Next, we investigated whether OrtT participates in a similar adaptive stress response with other 
antimicrobials. We took advantage of the PortEco database that indicates the results for large-scale 
phenotypic screening for all of the Keio mutants and that indicates ∆ortT has a negative fitness score 
for trimethoprim (TMP) [45]. TMP is an antifolate drug that inhibits the synthesis of THF by binding 
to dihydrofolate reductase (DHFR) [46]. THF plays vital role in synthesis of amino acid serine and 
methionine (Figure S5), and low THF induces the stringent response and causes bacteria to enter into a 
non-proliferating state [5]. In addition, THF is an essential precursor for purine and thymidine 
triphosphate synthesis (Figure S5) and interference with THF metabolism inhibits bacterial DNA 
synthesis [47]. We found that the ∆ortT ∆Kan mutant had dramatically higher metabolism compared to 
wild-type strain in response to 1 µg/mL TMP (Figure 4B), indicating OrtT acts as a metabolic brake to 
slow cellular metabolism under conditions that are unfavorable for amino acid and DNA synthesis. 
Critically, while the ∆ortT ∆Kan strain was metabolically active in the presence of TMP, the ∆ghoT 
∆Kan strain was as sensitive to TMP as the wild-type cells (Figure 4B). These results indicate that  
toxins OrtT and GhoT have different physiological roles in cell fitness even though they share 63% 
protein identity. 
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Figure 4. OrtT reduces cellular metabolism under THF-related antimicrobial stress.  
(A) Metabolic activity of the wild-type, ∆ortT ∆Kan, and ∆ghoT ∆Kan strains in response 
to 3 µg/mL carbenicillin or water (negative control); (B) Metabolic activity of the  
wild-type, ∆ortT ∆Kan, and ∆ghoT ∆Kan strains in response to 1 µg/mL TMP or DMSO 
(negative control); (C) Metabolic activity of the wild-type strain and ∆ortT ∆Kan in 
response to 60 µg/mL SMZ or DMSO (negative control). Two independent cultures were 
evaluated for each experiment. Error bar represents standard deviation. 
Furthermore, to corroborate that OrtT acts specifically in the THF synthesis pathway, we performed 
a similar metabolic assay using sulfamethoxazole (SMZ). SMZ is often used along with TMP for their 
synergistic effect against bacteria since SMZ inhibits dihydropteroate synthetase, whereas TMP 
inhibits DHFR [48] (Figure S6). As expected, the ∆ortT ∆Kan mutant showed higher metabolism 
compared to the wild-type host in response to 60 µg/mL SMZ (Figure 4C) which corroborates the 
previous result with TMP. 
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Since metabolic activity is measured at 590 nm and cell growth is measured at 600 nm,  
we suspected OrtT might also influence cell growth when challenged with TMP. To investigate this, 
we performed the growth assay with wild-type and ΔortT ∆Kan cells with or without TMP treatment. 
As expected, the mutant lacking ortT showed higher growth than that of the wild-type cells in the 
presence of TMP (Figure 5). Note that, the OD600 values for the growth experiment (Figure 5) are 
lower compared to the metabolic activity values at OD590 (Figure 4B) since the metabolic activity 
values include both growth and metabolism. Collectively, all these lines of evidence indicate that,  
OrtT is not a redundant GhoT-like toxin; rather, it is important for maintaining cell fitness during stress 
related to the stringent response. 
 
Figure 5. OrtT reduces cellular growth in the presence of TMP. Growth of the wild-type  
and ∆ortT ∆Kan strains in response to 0.5 and 1 µg/mL TMP or DMSO (negative control). 
Two independent cultures were evaluated for each experiment. Error bar represents  
standard deviation. 
2.5. Regulation of ortT 
Since cellular growth and metabolism was higher in the absence of ortT, we reasoned that ortT is 
activated during the stringent response. To explore this possibility, we studied whether ortT expression 
is elevated under several conditions that should elevate ppGpp using quantitative real-time  
reverse-transcription PCR (qRT-PCR). Four different conditions were used to induce the stringent 
response: TMP [49], native RelA production [50], mupirocin (MUP) [51], and serine hydroxamate 
(SHX) [52]; for all four conditions, ortT expression was induced (Tables 1 and S1). Among these, ortT 
expression was highest with SHX treatment and lowest with RelA production. The reason for such low 
expression of ortT in the case of RelA production could be that the activity of full-length native RelA 
protein is not constitutive and depends on amino-acid starvation condition [50]. 
To investigate the mechanism of ortT activation, we tested whether this toxin gene is expressed via 
the predicted sigma E and H-dependent promoters (Figure 3A) since sigma E (RpoE) is activated by 
ppGpp [53] and sigma H (RpoH) is under the regulation of sigma E [54]. We activated sigma E via  
heat-shock stress [55] and qRT-PCR showed that ortT was again activated (Tables 1 and S1).  
Therefore, these results demonstrate that OrtT plays a vital role in the adaptive stress response of the 
cells since ortT is induced under nutrient limiting conditions most likely via transcription factor  
sigma E and H. 
  
Toxins 2015, 7 309 
 
 
Table 1. Summary of qRT-PCR results to investigate whether ortT expression is induced 
under stringent conditions. All qRT-PCR experiments were performed with two biological 
replicates each with two technical replicates. 
Conditions Strains 
Fold Change of 
ortT Induction 
Treatment Description 
TMP treatment BW25113 3.1 ± 1.5 
Exponentially-growing cells were treated with 
TMP (75 µg/mL) for 2 h. 
RelA production 
BW25113/pCA24N 
BW25113/pCA24N-relA 
2.3 ± 0.6 
Exponentially-growing cells were treated with 
IPTG (1 mM) to induce RelA production for 2 h. 
MUP treatment BW25113 4.61 ± 0.29 
Exponentially-growing cells were treated with 
MUP (100 µg/mL) for 2 h. 
SHX treatment BW25113 89 ± 80 
Exponentially-growing cells were treated with 
SHX (1 mg/mL) for 2 h. 
Heat shock BW25113 2.0 ± 0.2 
Exponentially-growing cells were shifted from  
30 °C to 43 °C for 30 min. 
3. Discussion 
In our previous study, the physiological role of type V toxin GhoT was ascertained; GhoT causes 
membrane damage by reducing cellular ATP level and reduces metabolism in the presence of various 
antimicrobials related to cell-wall synthesis (i.e., carbenicillin and cefoxitin) [42]. In the present study, 
we have characterized a new GhoT-like toxin, OrtT, in E. coli. OrtT is a small, hydrophobic peptide 
that shares 63% protein identity with GhoT, and we have demonstrated that: (i) OrtT strongly inhibits 
growth and causes cell lysis; (ii) removal of the start codon encoding ortT restores growth proving 
OrtT is active as a protein; (iii) OrtT damages the cell membrane and depletes cellular ATP, (iv) the 
F38R substitution reduces OrtT toxicity; (v) unlike GhoT, OrtT is most likely an orphan toxin as it is 
neither encoded by a bicistronic operon nor under in trans regulation by an antitoxin encoded 
elsewhere in the genome; (vi) OrtT reduces cellular metabolism in the presence of antimicrobials like 
TMP and SMZ; and (vii) ortT is activated under stringent conditions; so, its role in cell physiology 
appears to be to reduce growth during nutritional stress. 
Based on the structural homology between GhoT and OrtT, we introduced the same mutation  
(i.e., F38R) in OrtT that allowed us previously to create a non-toxic version of GhoT [42] in order  
to characterize OrtT. Despite the absence of a hydrophobic interaction between Phe38 and Ile21  
(that presumably stabilized GhoT) in OrtT (Figure 2A), toxicity was reduced upon F38R substitution 
indicating OrtT might be functionally similar to GhoT. Moreover, similarities in the morphological 
changes in the membrane upon OrtT and GhoT production (visualized via TEM) indicates that these 
toxins might be utilized in a similar fashion by the cells to escape unfavorable environmental stimuli. 
Surprisingly, deletion of ortT did not have the same impact on metabolism in presence of carbenicillin 
as ghoT. In addition, ortT was advantageous for the cells in response to a completely different set of 
antibiotics, TMP and SMZ, related to THF synthesis whereas the ghoT mutation was unrecognizable 
under the same conditions. Hence, OrtT serves a different physiological role than GhoT. 
Furthermore, ortT mRNA contains two MqsR-preferred 5'-GCU cleavage sites [56] which are 
absent in ghoT mRNA indicating OrtT is likely not active under conditions that activate MqsR whereas 
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MqsR activates GhoT [32]. Unlike GhoT, OrtT also increases swarming motility [57]. Collectively, 
our results demonstrate that OrtT is a new toxin despite being a homolog of GhoT. Our findings 
indicate that cells utilize these two similar toxins for different physiological roles; i.e., they utilize the 
two toxins for different stress conditions. The reduced growth via OrtT under TMP antimicrobial stress 
could be an outcome of energy depletion from membrane damage by OrtT just like GhoT [42]; 
however, closer scrutiny is required to evaluate the molecular mechanism of how these toxins are activated 
in response to specific environmental cues (i.e., reduction in THF level or nutrient limiting condition). 
TMP treatment causes immediate accumulation of ppGpp [49] as it reduces THF and induces the 
stringent response. This nutritional stress response is triggered by the initial rapid depletion of  
glycine [5]. If glycine is supplied exogenously, the second metabolite pool to be exhausted is ATP [5]. 
ortT is predicted to be under RpoE (σE) and RpoH (σH) regulation, and our results confirm this 
prediction. RpoE is the stress response sigma factor for extracytoplasmic stress [53]. However, RpoE 
is also induced by the stringent response alarmone ppGpp [53]. Furthermore, the heat shock sigma 
factor RpoH is induced by RpoE [54]. This suggests that accumulation of ppGpp due to glycine 
depletion induces ortT expression via activation of RpoH and RpoE. OrtT in turn damages cellular 
membrane and contributes to reduce the intracellular ATP due to PMF disruption or via direct leakage 
of intracellular ATP. In this manner, when THF is depleted, the stringent response is activated to shut 
down growth via accumulation of ppGpp and OrtT (Figure 6). Therefore, OrtT appears to be part of 
the stringent response, and since it lacks an antitoxin, perhaps OrtT is employed as a “fail-safe” 
regulator, the activation of which ensures attainment of a non-growing state even faster through 
exhaustion of the ATP pool. 
4. Experimental Section 
4.1. Bacterial Strains, Plasmids, and Growth Conditions 
The bacterial strains and plasmids used in this study are listed in Table 2. All experiments were 
conducted in lysogeny broth (LB) [58] at 37 °C unless stated otherwise. The Keio collection [59] was 
used to compare isogenic single gene mutations, and the ASKA library [60] was used to produce 
proteins in E. coli. The kanamycin resistance cassette was removed from ΔortT using pCP20 [61] and 
the ortT deletion and kanamycin cassette removal were verified by PCR amplification using the  
ortT-up-F and ortT-down-R primers (Table 3) and by sequencing the PCR product using the ortT-up-F 
primer. Cell growth was assayed using the turbidity at 600 nm, chloramphenicol (30 µg/mL) was used 
to maintain the pCA24N-based plasmids [60], and kanamycin (50 µg/mL) was used to maintain  
pBS(Kan)-based plasmids [62]. 
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Figure 6. Schematic of proposed mechanism for OrtT-mediated reduction in metabolism 
under stringent condition. Stringent response or ppGpp accumulation is induced under 
nutritional stress. TMP treatment also induces ppGpp as reduction in THF level leads to 
depletion in glycine and methionine. Increased amount of ppGpp then activates the 
alternative sigma factor RpoE. RpoE in turn activates another stress-related sigma factor 
RpoH. ortT is under RpoE and RpoH regulation and this way, OrtT is activated to damage 
cellular membrane and to reduce intracellular ATP level. Thus, activation of OrtT leads to 
reduction in cellular metabolism during stringent response. The symbol → indicates 
induction and  indicates repression. 
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Table 2. Bacterial strains and plasmids used in this study. Double colon (::) indicates 
fusion of a promoter and gene. 
Strains Genotype Source 
BW25113 rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 rph-1 [59] 
BW25113 ∆ortT BW25113 ΔortT Ω KmR [59] 
BW25113 ∆ghoT ∆kan BW25113 ΔghoT [42] 
BW25113 ∆ortT ∆kan BW25113 ΔortT This study 
BW25113 ∆mqsR ∆mqsA ∆kan BW25113 ∆mqsR ∆mqsA [43] 
Plasmids Genotype Source 
pCA24N CmR; lacIq [60] 
pCA24N-ghoT CmR; lacIq, PT5-lac::ghoT+ [60] 
pCA24N-ortT CmR; lacIq, PT5-lac::ortT+ [60] 
pCA24N-relA CmR; lacIq, PT5-lac::relA+ [60] 
pCA24N-ortTACG CmR; lacIq, PT5-lac::ortT+ with start codon ATG replaced with ACG This study 
pCA24N-ortTF38R 
CmR; lacIq, PT5-lac::ortT+ with TT changed to CG at nucleotide position 
160-161 relative to the 6xHis-GhoT start codon 
This study 
pCA24N-ghoTF38R 
CmR; lacIq, pCA24N PT5-lac::ghoT+ with TT changed to CG at 
nucleotide position 160-161 relative to the 6xHis-GhoT start codon 
[42] 
pCA24N-ortT-ydcY CmR; lacIq, pCA24N PT5-lac::ortT+-ydcY+ This study 
pCA24N-ortT-ghoS CmR; lacIq, pCA24N PT5-lac::ortT+-ghoS+ This study 
pCA24N-ortT-B 
CmR; lacIq, pCA24N PT5-lac::ortT+ with the BamHI site in  
the N-terminus linker deleted. 
This study 
pCP20 ApR; CmR, FLP+, λ cI857+, λ pRRepts [61] 
pBS(Kan) KmR; cloning vector [62] 
pBS(Kan)-mqsR KmR; pBS(Kan) Plac::mqsR+ [43] 
pBS(Kan)-mqsR-mqsA KmR; pBS(Kan) Plac::mqsR+-mqsA+ [43] 
CmR and KmR are chloramphenicol and kanamycin resistance, respectively. 
Table 3. Oligonucleotides used for plasmid construction (synthetic RBS is double 
underlined), site directed mutagenesis (target mutated nucleotides are underlined), 
verification of kanamycin cassette removal, and qRT-PCR. 
Purpose/Name Sequence (5' to 3') 
Plasmid construction 
ydcY-SalI-F TTTTTTGTCGACATTAAAGAGGAGAAATTAACTATGTCGCATCTGGATGAAGTCA 
ydcY-HindIII-R TTTTTTGTCGACAAGCTTAGACGCTCATTTTAATCAGAGGATGGTG 
ghoS-SalI-F TTTTTTGTCGACATTAAAGAGGAGAAATTAACTATGGAAGGTAAAAACAAGTTCAATAC 
ghoS-HindIII-R TTTTTTGTCGACAAGCTTCTTATCCTTCCTGGCTACTTGTAAAACTGAC 
UTR-F TTTTTTGTCGACACAGTTCTACTGGAAACATTCATTTTTGC 
UTR-R TTTTTTAAGCTTCAATTTGTGGCGCAATTTTACTTGTG 
Site-directed mutagenesis 
ghoT-ACG-F AAAGAGGAGAAATTAACTACGAGAGGATCTCACCAT 
ghoT-ACG-R ATGGTGAGATCCTCTCGTAGTTAATTTCTCCTCTTT 
ortTF38R-F TCCGTTTCTTAAGCGCCCGTCTGGTGGGGGCAAC 
ortTF38R-R ATGTTGCCCCCACCAGACGGGCGCTTAAGAAACGGA 
ortT-ACG-Chrom-F GACGCCCGTACACGTCTCTCTATCAACA 
ortT-ACG-Chrom-R TGTTGATAGAGAGACGTGTACGGGCGTC 
BamHI-F GAGGATCTCACCATCACCATCACCATACGGCCCTGAGGGCCTCTCTCTATCAACAC 
BamHI-R GTGTTGATAGAGAGAGGCCCTCAGGGCCGTATGGTGATGGTGATGGTGAGATCCTC 
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Table 3. Cont. 
Purpose/Name Sequence (5' to 3') 
Verification of Kan insertion/removal 
ortT-up-F ATGGATAAGGGCAAGTTGCTGTTTGATG 
ortT-down-R CCAATTTGTGGCGCAATTTTACTTGTG 
qRT-PCR 
gyrA-F GTCATGCCAACCAAAATTCCTAAC 
gyrA-R TCATCATCAATATACGCCAGACAAC 
ortT-F AATCGCATTTCTTATCACCTGG 
ortT-R GAAACTCATCGGCCATGTTG 
F indicates forward primer and R indicates reverse primer. 
4.2. Construction of pCA24N-ortT-ydcY, pCA24N-ortT-ghoS, and pCA24N-ortT-UTR 
The putative antitoxin genes, ydcY and ghoS were PCR-amplified from E. coli K12 BW25113 
chromosomal DNA using primer pair ydcY-SalI-F/ydcY-HindIII-R and ghoS-SalI-F/ghoS-HindIII-R 
respectively. The forward primers were designed to include the synthetic RBS from pCA24N  
plasmid [60] (Table 3). The pCA24N-ortT-UTR plasmid was constructed by cloning the intervening 
DNA flanking ortT from the BW25113 chromosome into pCA24N-ortT. To do so, the 217 bp 
upstream intergenic region (between yncL and ortT), an inactivated ortT (174 bp), and the 381 bp 
downstream intergenic region including ydcY (a total of 772 bp, Figure S2D) was PCR amplified using 
UTR-F/R primer pair (Table 3). The chromosomal ortT gene was inactivated by changing the start 
codon (i.e., ATG→ACG) via site-directed mutagenesis using the primer pair ortT-ACG-chrom-F/R 
(Table 3) so that the final plasmid (i.e., pCA24N-ortT-UTR) that was used in the growth experiment 
(Figure 3B) had only one copy of active ortT like the other two plasmids (i.e., pCA24N-ortT-ydcY and  
pCA24N-ortT-ghoS). PCR products were purified using a Promega PCR product purification kit 
(Promega, Madison, WI, USA). The purified PCR product and the vector pCA24N-ortT were digested 
with SalI and HindIII restriction enzymes (New England Biolabs, Beverly, MA, USA) and then ligated 
using T4 DNA ligase. The ligation mixture was transformed into BW25113 competent cells and the 
resulted plasmids were verified by sequencing. 
4.3. Genomic Library Construction 
The genome library was constructed by using BamHI (to cut the vector) and Sau3AI (to cut the 
genomic DNA) restriction enzymes (New England Biolabs, Beverly, MA, USA) that produce 
compatible overhangs. Since there are two BamHI sites in the ASKA plasmid pCA24N-ortT (i.e.,  
one in the N-terminus linker of ortT and the second downstream of ortT), the vector was modified by 
deleting the first BamHI site in the pCA24N-ortT plasmid via site-directed mutagenesis with the 
BamHI-F/R primer pair (Table 3). The resulting plasmid, pCA24N-ortT-B (with a single BamHI site) 
was digested with BamHI and dephosphorylated with rSAP phosphatase (New England Biolabs, 
Beverly, MA, USA) to prevent self-ligation. BW25113 genomic DNA was partially digested with 
Sau3AI and ~2–4 Kb genome fragments were gel-purified and ligated into the linearized vector using 
T4 DNA ligase. The ligation mixture was transformed into BW25113 competent cells. The library 
construction was verified by sequencing three random clones (that were not challenged with IPTG), 
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which had inserts mapping to different places in the genome (i.e., fragments including bepA, yiaU, and 
elfG). The average insert size of the library was 622 bp found by digesting the plasmids obtained from 
25 random clones with SapI (cuts near the origin of the plasmids). The library was then screened by 
growing the clones with 1 mM IPTG to induce ortT expression. Surviving clones (~0.25% of the library) 
that grew in presence of IPTG were analyzed by digesting their plasmids with AflII which cuts within 
the ortT coding region; none of the plasmids were cut by AflII whereas the plasmids could be  
digested with SapI. Moreover, the linearized plasmids were shorter compared to the plasmid that 
contains ortT (pCA24N-ortT-B) which indicates the toxin gene was missing in the survivor plasmids. 
Approximately, 21,314 clones were screened in this experiment; hence, the genome coverage was  
2.9 times (i.e., 21,314 clones × 622 bp/4.6 Mbp). 
4.4. Site-Directed Mutagenesis 
Site-directed mutagenesis PCR was performed using pCA24N-ortT (Table 2) as the template with 
ghoT-ACG-f/ghoT-ACG-r for removing the start codon and with ortTF38R-f/ortTF38R-r for changing 
Phe38 to Arg (Table 3). The PCR products were recovered subjected to DpnI digestion for removing 
the template plasmids and the digestion product were then transformed into E. coli BW25113  
wild-type competent cells. The plasmids were isolated from resulted transformants and the desired 
mutations were confirmed by sequencing check (Table 2). 
4.5. Toxicity Assay 
For the toxicity assays, overnight cultures were refreshed in fresh LB medium with chloramphenicol 
to an initial turbidity at 600 nm of 0.05, cells were allowed to grow to turbidity of 0.1, induced with  
1 mM IPTG (for OrtT is a proteic toxin and OrtT is an orphan toxin) or 0.1 mM IPTG (for growth 
assays with F38R mutants) and turbidity at 600 nm was recorded every hour for monitoring cell 
growth. For performing streak toxicity tests, overnight cultures were streaked on LB plates 
supplemented with chloramphenicol and with or without IPTG (same as liquid growth test) and 
incubated overnight. 
4.6. Lysis Assay 
To determine whether OrtT overexpression causes cell lysis, overnight cultures were refreshed in 
fresh LB medium with chloramphenicol to an initial turbidity at 600 nm of 0.05, cells were grown to 
turbidity of 0.5, then induced with 2 mM IPTG (time zero). Cell sample was collected every 30 min by 
harvesting 1 mL culture for assessing cell viability. Harvested cell pellets were washed and  
diluted by 102 to 107 via 10-fold serial dilution steps in 0.85% NaCl solution and 10 µL of diluted cell  
suspension was plated on LB agar plate with chloramphenicol for enumerating colony forming unit 
(CFU) per mL [63]. 
4.7. TEM 
TEM was performed for overexpressing OrtT as described previously [42]. For preparing cell 
samples for TEM, overnight cultures of BW25113/pCA24N-ortT and BW25113/pCA24N-(-gfp) were 
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refreshed to a turbidity at 600 nm of 0.05, grown in LB-chloramphenicol to a turbidity at 600 nm of 
0.2, and then 1 mM of IPTG was added to induce OrtT production for 4 h. Cells were harvested and 
fixed with primary fixative (1.5% paraformaldehyde and 2.5% glutaraldehyde, and 4% sucrose in  
100 mM of sodium cacodylate buffer, pH 7.4) at room temperature for 15 min, then 4 °C for 12 h. Cell 
pellets were then washed three times with buffer (0.1 M sodium cacodylate buffer, pH 7.4) for 5 min. 
Secondary fixation was carried by fixing the cell pellets with 1% osmium tetroxide in buffer for 1 h in 
dark, followed by three washes with buffer and one wash with sterile MilliQ water. Cells were then 
subjected to en bloc staining by treating with 2% uranyl acetate in the dark for 1 h. Next, dehydration 
step was performed by applying a graded ethanol series (50%, 70%, 85%, 95% and three times with 
100% ethanol, for 5 min each), and 100% acetone (three times, 5 min each). The dehydrated cells were 
then embedded into epoxy resins after three epoxy exchange for at least 12 h at 60 °C. The hardened 
cell samples were then sectioned into thin specimens (70 nm thick) using an ultramicrotome  
(UC6, Leica, Buffalo Grove, IL, USA). Positive staining was performed by staining the specimens 
with uranyl acetate for 6 min and lead citrate for another 6 min. The stained specimens were then 
examined on a FEI Tecnai G2 Spirit BioTwin TEM (Penn State Microscopy and Cytometry Facility,  
University Park, PA, USA) at an accelerating voltage of 120 kV. 
4.8. ATP Assay 
The ATP assay was conducted as described previously [42] using the luciferase kit (ENLITEN ATP 
assay, Promega, Madison, WI, USA). The RLU values were normalized for growth by the optical 
density (600 nm) at the time of harvest for each sample and were converted to relative numbers using 
the values of the strain with the empty plasmid. 
4.9. Persister Assay 
The persister assay was conducted as described [27]. Briefly, overnight cultures were diluted to an 
initial turbidity at 600 nm of 0.05 and grown with chloramphenicol (30 µg/mL) to a turbidity of 1.0, 
then 1 mM IPTG was used to induce OrtT. After 2 h of induction, cells were washed, adjusted to a 
turbidity of 1.0 with chloramphenicol (30 µg/mL), and were treated with ampicillin (100 µg/mL) or 
ciprofloxacin (5 µg/mL) for another 3 h. Cell viability was determined for each sample before and 
after ampicillin treatment by applying 10 µL drops in serial dilutions [63] plates with chloramphenicol. 
Two independent cultures per strain were evaluated. 
4.10. Metabolism and Relevant Growth Assay 
Metabolic activities in response to antimicrobials were assayed using reagents from Biolog, Inc. 
(Hayward, CA, USA) following BioLog’s procedure [64]. Briefly, cells were grown to turbidity at  
600 nm of 1.0, diluting to a turbidity of 0.07 in IF-10a (Cat. No. 72264), and then further diluted  
200 fold into a reagent mixture containing IF-10a, BioLog Redox Dye D (Cat. No. 74224) and a rich 
medium (2.0 g of tryptone, 1.0 g of yeast extract, and 1.0 g of NaCl per liter) to a final turbidity of 
0.00035. Next, 90 µL volume of this diluted cell suspension was transferred into 96-well microtiter 
plates prepared with 10 µL of 10× antibiotics (i.e., carbenicillin, TMP, and SMZ), or solvent only  
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(water or DMSO). The metabolic activity (NADH production) was monitored by taking hourly 
measurement of the absorbance at 590 nm which indicates the intracellular reducing state based on the 
generation of formazane (purple) from the tetrazolium dye. For performing the growth assay under 
these conditions, the BioLog Redox Dye was replaced with water and growth was monitored by 
measuring the absorbance at 600 nm. 
4.11. qRT-PCR 
Total RNA was isolated as described previously [65] using Qiagen RNeasy mini kit (Valencia, CA, 
USA). Overnight cultures were diluted in 25 mL M9 medium [58] supplemented with 0.4% glucose  
to an initial turbidity at 600 nm of 0.05. For stringent conditions, the inducer (i.e., 75 µg/mL TMP,  
100 µg/mL MUP, 1 mg/mL SHX or 1 mM IPTG for relA induction) was added when the cells reached 
the exponential phase (turbidity at 600 nm of 0.2~0.4), and the cells were induced for 2 h before 
isolating RNA. For TMP, MUP, and SHX treatment, BW25113 was used. For RelA production, 
BW25113 carrying pCA24N-relA (Table 2) or empty plasmid pCA24N (negative control) were used. 
For the heat-shock stress experiment, overnight cultures of BW25113 were diluted in M9 medium 
supplemented with 0.4% glucose and 0.4% casamino acid, and cells were then incubated at 30 °C.  
In the exponential phase (turbidity at 600 nm of 0.3), 10 mL cell samples were harvested for the no 
stress control, and the rest of the cells were heat shocked by incubating at 43 °C for 30 min. qRT-PCR 
was performed according to the manufacturer’s instructions using the Power SYBR Green RNA-to-CT 
1-Step kit (Life Technologies, Carlsbad, CA, USA) using 100 ng of total RNA as the template. Primers 
(Table 3) were annealed at 60 °C, and fold changes were calculated using 2−∆∆CT formula [66] with 
gyrA as the internal control for normalizing all data. 
4.12. Additional Methods 
Conditions for tricine-SDS-PAGE and the Western blot analysis are described in the  
Supplementary Methods. 
5. Conclusions 
Although previous studies have predicted independent occurrences of toxins [67–69], demonstration 
of an active orphan toxin has not been achieved previously. Our results show that there is a possibility 
that a toxin can exist solely by itself, and it does so with a distinct biological role related to the 
stringent response. These findings raise an intriguing question as to why the cells have a toxin in the 
chromosome that is not “guarded” by an antitoxin. It appears that instead of an antitoxin, another 
strategy is that cells may regulate toxins via tight regulation such as the two tandem promoters 
regulated by alternative sigma factors as demonstrated for ortT. Further research is required to 
determine how OrtT is inactivated after stress; however, our results create a new simpler paradigm for 
reducing cellular metabolism during stress using an orphan toxin. 
Supplementary Materials 
Supplementary materials can be accessed at: http://www.mdpi.com/2072-6651/7/2/0299/s1. 
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